Matches in SemOpenAlex for { <https://semopenalex.org/work/W3200726652> ?p ?o ?g. }
- W3200726652 abstract "Immunotherapy is a novel clinical approach that has shown clinical efficacy in multiple cancers. However, only a fraction of patients respond well to immunotherapy. Immuno-oncological studies have identified the type of tumors that are sensitive to immunotherapy, the so-called hot tumors, while unresponsive tumors, known as “cold tumors,” have the potential to turn into hot ones. Therefore, the mechanisms underlying cold tumor formation must be elucidated, and efforts should be made to turn cold tumors into hot tumors. N 6 -methyladenosine (m 6 A) RNA modification affects the maturation and function of immune cells by controlling mRNA immunogenicity and innate immune components in the tumor microenvironment (TME), suggesting its predominant role in the development of tumors and its potential use as a target to improve cancer immunotherapy. In this review, we first describe the TME, cold and hot tumors, and m 6 A RNA modification. Then, we focus on the role of m 6 A RNA modification in cold tumor formation and regulation. Finally, we discuss the potential clinical implications and immunotherapeutic approaches of m 6 A RNA modification in cancer patients. In conclusion, m 6 A RNA modification is involved in cold tumor formation by regulating immunity, tumor-cell-intrinsic pathways, soluble inhibitory mediators in the TME, increasing metabolic competition, and affecting the tumor mutational burden. Furthermore, m 6 A RNA modification regulators may potentially be used as diagnostic and prognostic biomarkers for different types of cancer. In addition, targeting m 6 A RNA modification may sensitize cancers to immunotherapy, making it a promising immunotherapeutic approach for turning cold tumors into hot ones." @default.
- W3200726652 created "2021-09-27" @default.
- W3200726652 creator A5011194703 @default.
- W3200726652 creator A5017110459 @default.
- W3200726652 creator A5017121652 @default.
- W3200726652 creator A5017947172 @default.
- W3200726652 creator A5021711298 @default.
- W3200726652 creator A5022287594 @default.
- W3200726652 creator A5025115516 @default.
- W3200726652 creator A5025993434 @default.
- W3200726652 creator A5061718211 @default.
- W3200726652 creator A5076112088 @default.
- W3200726652 date "2021-09-20" @default.
- W3200726652 modified "2023-09-23" @default.
- W3200726652 title "N6-Methyladenosine RNA Modification: An Emerging Immunotherapeutic Approach to Turning Up Cold Tumors" @default.
- W3200726652 cites W1895681508 @default.
- W3200726652 cites W1941339056 @default.
- W3200726652 cites W1944707476 @default.
- W3200726652 cites W1981629946 @default.
- W3200726652 cites W1990602451 @default.
- W3200726652 cites W1994033656 @default.
- W3200726652 cites W2049491375 @default.
- W3200726652 cites W2060070314 @default.
- W3200726652 cites W2065847836 @default.
- W3200726652 cites W2071930821 @default.
- W3200726652 cites W2078964320 @default.
- W3200726652 cites W2085106808 @default.
- W3200726652 cites W2091235283 @default.
- W3200726652 cites W2104774845 @default.
- W3200726652 cites W2107429737 @default.
- W3200726652 cites W2116554142 @default.
- W3200726652 cites W2127079528 @default.
- W3200726652 cites W2128402485 @default.
- W3200726652 cites W2132762486 @default.
- W3200726652 cites W2148317624 @default.
- W3200726652 cites W2152283027 @default.
- W3200726652 cites W2154697747 @default.
- W3200726652 cites W2165547003 @default.
- W3200726652 cites W2167973264 @default.
- W3200726652 cites W2269054226 @default.
- W3200726652 cites W2306179365 @default.
- W3200726652 cites W2338576144 @default.
- W3200726652 cites W2403990263 @default.
- W3200726652 cites W2472887612 @default.
- W3200726652 cites W2507685096 @default.
- W3200726652 cites W2528388077 @default.
- W3200726652 cites W2552643092 @default.
- W3200726652 cites W2575691519 @default.
- W3200726652 cites W2578506026 @default.
- W3200726652 cites W2588097017 @default.
- W3200726652 cites W2596050358 @default.
- W3200726652 cites W2596054989 @default.
- W3200726652 cites W2602291642 @default.
- W3200726652 cites W2605630275 @default.
- W3200726652 cites W2607136415 @default.
- W3200726652 cites W2613208586 @default.
- W3200726652 cites W2728594144 @default.
- W3200726652 cites W2743522323 @default.
- W3200726652 cites W2749219966 @default.
- W3200726652 cites W2764301500 @default.
- W3200726652 cites W2765620447 @default.
- W3200726652 cites W2772792536 @default.
- W3200726652 cites W2780852610 @default.
- W3200726652 cites W2790194840 @default.
- W3200726652 cites W2791349417 @default.
- W3200726652 cites W2791790309 @default.
- W3200726652 cites W2800471491 @default.
- W3200726652 cites W2801309958 @default.
- W3200726652 cites W2886253007 @default.
- W3200726652 cites W2891713480 @default.
- W3200726652 cites W2903232633 @default.
- W3200726652 cites W2907564726 @default.
- W3200726652 cites W2909679049 @default.
- W3200726652 cites W2910561108 @default.
- W3200726652 cites W2911349862 @default.
- W3200726652 cites W2912369228 @default.
- W3200726652 cites W2920600229 @default.
- W3200726652 cites W2921763102 @default.
- W3200726652 cites W2936182511 @default.
- W3200726652 cites W2939354927 @default.
- W3200726652 cites W2939559050 @default.
- W3200726652 cites W2944219340 @default.
- W3200726652 cites W2948955366 @default.
- W3200726652 cites W2950126013 @default.
- W3200726652 cites W2952065098 @default.
- W3200726652 cites W2953460056 @default.
- W3200726652 cites W2953467762 @default.
- W3200726652 cites W2955121251 @default.
- W3200726652 cites W2969469813 @default.
- W3200726652 cites W2972178290 @default.
- W3200726652 cites W2977905919 @default.
- W3200726652 cites W2987385271 @default.
- W3200726652 cites W2990016380 @default.
- W3200726652 cites W2994203027 @default.
- W3200726652 cites W2994993265 @default.
- W3200726652 cites W2995603927 @default.
- W3200726652 cites W2995779974 @default.
- W3200726652 cites W2997492439 @default.
- W3200726652 cites W3000547706 @default.
- W3200726652 cites W3001439289 @default.